JAK-2 Mutation (CPMD) (V617F) by RT-PCR

The JAK-2 Mutation (CPMD) (V617F) by RT-PCR test is a diagnostic blood test that detects a specific mutation in the JAK-2 gene, which is associated with certain blood disorders such as polycythaemia vera, essential thrombocytopenia, and primary myelofibrosis.

At healthcare nt sickcare, we offer the JAK-2 Mutation (CPMD) (V617F) by RT-PCR test as part of our comprehensive range of medical testing services. This test is useful in diagnosing and monitoring these blood disorders.

During the test, a healthcare professional will draw a blood sample from the patient's arm. The sample is then analysed in the lab using a RT-PCR technique to detect the JAK-2 mutation.

The JAK-2 Mutation (CPMD) (V617F) by RT-PCR test is a safe and non-invasive diagnostic test that can provide valuable information about a patient's genetic status. This test is recommended for individuals who have symptoms of the above-mentioned blood disorders, such as headaches, dizziness, weakness, and abnormal blood clotting.

At healthcare nt sickcare, we are committed to providing our patients with accurate and reliable medical testing services in a comfortable and convenient environment. Our JAK-2 Mutation (CPMD) (V617F) by RT-PCR test is just one of the many tests we offer to help diagnose and manage blood disorders.